EN
|
LT
| Trade mark | ||
|---|---|---|
| (210) | Application number | RL 8453 |
| (220) | Date of filing the application | 1993-06-02 |
| (111) | Registration number | 10108 |
| (151) | Registration date | 1994-03-22 |
| (181) | Expire | 2013-06-02 |
| (450) | Date of registration publication, bulletin No. | 1994-05-15, 1994/5 |
| Legal status |
Ended
|
|
| Reproduction of the mark | ||
| (540) | DANOL-DANAZOL | |
| (531) | Indication of Vienna Classification | |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 farmaciniai preparatai sintezės stabdymui ir/arba hipofizinių gonadotropinų išskyrimo stabdymui (ampulių, kapsulių ir tablečių formos). |
|
| Applicant (731) / Owner (732) | ||
| (732) | Name | Sanofi-Aventis |
| Address | 174 avenue de France F-75013 Paris | |
| Country | FR | |
| Attorney or representative | ||
| (740) | Name | Tatjana Sterlina |
| Address | UAB "Intels", Naugarduko g. 32 / 2, LT-03225 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | |
| Date | ||
| Country | ||
| Registration in the former USSR / International registration data | ||
| (646) | Number, date of filing, country, bulletin number | 77771, 1985-01-21, SU, 1994 / 5 |